(2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride

C27H35ClN4O2 — CID 154944167

IUPAC(2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride
SMILESCc1nn(Cc2ccccc2)c(C(C)O)c1-c1ccc(NC(=O)[C@@H](N)C2CCCCC2)cc1.Cl
InChIInChI=1S/C27H34N4O2.ClH/c1-18-24(26(19(2)32)31(30-18)17-20-9-5-3-6-10-20)21-13-15-23(16-14-21)29-27(33)25(28)22-11-7-4-8-12-22;/h3,5-6,9-10,13-16,19,22,25,32H,4,7-8,11-12,17,28H2,1-2H3,(H,29,33);1H/t19?,25-;/m0./s1
InChIKeyXNWPSBSDSCUHHO-VAMRJWDISA-N
MW483.06 g/mol
LogP5.23
Rot. Bonds7

About (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride

(2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride (PubChem CID 154944167) has the molecular formula C27H35ClN4O2 and a molecular weight of 483.06 g/mol. Its IUPAC name is (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride.

Molecular Properties

Compound Name(2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride
PubChem CID154944167
Molecular FormulaC27H35ClN4O2
Molecular Weight483.06 g/mol
Exact Mass482.24
IUPAC Name(2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride
SMILESCc1nn(Cc2ccccc2)c(C(C)O)c1-c1ccc(NC(=O)[C@@H](N)C2CCCCC2)cc1.Cl
InChIInChI=1S/C27H34N4O2.ClH/c1-18-24(26(19(2)32)31(30-18)17-20-9-5-3-6-10-20)21-13-15-23(16-14-21)29-27(33)25(28)22-11-7-4-8-12-22;/h3,5-6,9-10,13-16,19,22,25,32H,4,7-8,11-12,17,28H2,1-2H3,(H,29,33);1H/t19?,25-;/m0./s1
InChIKeyXNWPSBSDSCUHHO-VAMRJWDISA-N
XLogP5.23
TPSA93.17 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500483.06
LogP ≤ 55.23
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride?
The IUPAC name of (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride (CID 154944167) is (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride.
What is the SMILES notation for (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride?
The canonical SMILES for (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride is Cc1nn(Cc2ccccc2)c(C(C)O)c1-c1ccc(NC(=O)[C@@H](N)C2CCCCC2)cc1.Cl.
What is the InChIKey of (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride?
The InChIKey is XNWPSBSDSCUHHO-VAMRJWDISA-N. The full InChI is InChI=1S/C27H34N4O2.ClH/c1-18-24(26(19(2)32)31(30-18)17-20-9-5-3-6-10-20)21-13-15-23(16-14-21)29-27(33)25(28)22-11-7-4-8-12-22;/h3,5-6,9-10,13-16,19,22,25,32H,4,7-8,11-12,17,28H2,1-2H3,(H,29,33);1H/t19?,25-;/m0./s1.
What are the key properties of (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride?
(2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride has a molecular weight of 483.06 g/mol, XLogP of 5.23, 7 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-amino-N-[4-[1-benzyl-5-(1-hydroxyethyl)-3-methylpyrazol-4-yl]phenyl]-2-cyclohexylacetamide;hydrochloride is sourced from PubChem (CID 154944167), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).